BACKGROUND: The Duffy-null trait and ethnic netropenia are both highly prevalent in Africa. The influence of pre-seroconversion levels of peripheral blood cell counts (PBCs) on the risk of acquiring human immunodeficiency virus (HIV)-1 infection among Africans is unknown. METHODS: The triangular relationship among pre-seroconversion PBC counts, host genotypes, and risk of HIV acquisition was determined in a prospective cohort of black South African high-risk female sex workers. Twenty-seven women had seroconversion during follow-up, and 115 remained HIV negative for 2 years, despite engaging in high-risk activity. RESULTS: Pre-seroconversion neutrophil counts in women who subsequently had seroconversion were significantly lower, whereas platelet counts were higher, compared with those who remained HIV negative. Comprising 27% of the cohort, subjects with pre-seroconversion neutrophil counts of <2500 cells/mm(3) had a ∼3-fold greater risk of acquiring HIV infection. In a genome-wide association analyses, an African-specific polymorphism (rs2814778) in the promoter of Duffy Antigen Receptor for Chemokines (DARC -46T > C) was significantly associated with neutrophil counts (P = 7.9 × 10(-11)). DARC -46C/C results in loss of DARC expression on erthyrocytes (Duffy-null) and resistance to Plasmodium vivax malaria, and in our cohort, only subjects with this genotype had pre-seroconversion neutrophil counts of <2500 cells/mm(3). The risk of acquiring HIV infection was ∼3-fold greater in those with the trait of Duffy-null-associated low neutrophil counts, compared with all other study participants. CONCLUSIONS: Pre-seroconversion neutrophil and platelet counts influence risk of HIV infection. The trait of Duffy-null-associated low neutrophil counts influences HIV susceptibility. Because of the high prevalence of this trait among persons of African ancestry, it may contribute to the dynamics of the HIV epidemic in Africa.
BACKGROUND: The Duffy-null trait and ethnic netropenia are both highly prevalent in Africa. The influence of pre-seroconversion levels of peripheral blood cell counts (PBCs) on the risk of acquiring human immunodeficiency virus (HIV)-1 infection among Africans is unknown. METHODS: The triangular relationship among pre-seroconversion PBC counts, host genotypes, and risk of HIV acquisition was determined in a prospective cohort of black South African high-risk female sex workers. Twenty-seven women had seroconversion during follow-up, and 115 remained HIV negative for 2 years, despite engaging in high-risk activity. RESULTS: Pre-seroconversion neutrophil counts in women who subsequently had seroconversion were significantly lower, whereas platelet counts were higher, compared with those who remained HIV negative. Comprising 27% of the cohort, subjects with pre-seroconversion neutrophil counts of <2500 cells/mm(3) had a ∼3-fold greater risk of acquiring HIV infection. In a genome-wide association analyses, an African-specific polymorphism (rs2814778) in the promoter of Duffy Antigen Receptor for Chemokines (DARC -46T > C) was significantly associated with neutrophil counts (P = 7.9 × 10(-11)). DARC -46C/C results in loss of DARC expression on erthyrocytes (Duffy-null) and resistance to Plasmodium vivax malaria, and in our cohort, only subjects with this genotype had pre-seroconversion neutrophil counts of <2500 cells/mm(3). The risk of acquiring HIV infection was ∼3-fold greater in those with the trait of Duffy-null-associated low neutrophil counts, compared with all other study participants. CONCLUSIONS: Pre-seroconversion neutrophil and platelet counts influence risk of HIV infection. The trait of Duffy-null-associated low neutrophil counts influences HIV susceptibility. Because of the high prevalence of this trait among persons of African ancestry, it may contribute to the dynamics of the HIV epidemic in Africa.
Authors: Shaun Purcell; Benjamin Neale; Kathe Todd-Brown; Lori Thomas; Manuel A R Ferreira; David Bender; Julian Maller; Pamela Sklar; Paul I W de Bakker; Mark J Daly; Pak C Sham Journal: Am J Hum Genet Date: 2007-07-25 Impact factor: 11.025
Authors: P C Sabeti; S F Schaffner; B Fry; J Lohmueller; P Varilly; O Shamovsky; A Palma; T S Mikkelsen; D Altshuler; E S Lander Journal: Science Date: 2006-06-16 Impact factor: 47.728
Authors: Alexandra M Levine; Roksana Karim; Wendy Mack; D Jay Gravink; Katherine Anastos; Mary Young; Mardge Cohen; Meg Newman; Michael Augenbraun; Stephen Gange; D Heather Watts Journal: Arch Intern Med Date: 2006-02-27
Authors: Matthew M Hsieh; James E Everhart; Danita D Byrd-Holt; John F Tisdale; Griffin P Rodgers Journal: Ann Intern Med Date: 2007-04-03 Impact factor: 25.391
Authors: Hemant Kulkarni; Vincent C Marconi; Weijing He; Michael L Landrum; Jason F Okulicz; Judith Delmar; Dickran Kazandjian; John Castiblanco; Seema S Ahuja; Edwina J Wright; Robin A Weiss; Robert A Clark; Matthew J Dolan; Sunil K Ahuja Journal: Blood Date: 2009-07-20 Impact factor: 22.113
Authors: Nicole M Walley; Boris Julg; Samuel P Dickson; Jacques Fellay; Dongliang Ge; Bruce D Walker; Mary Carrington; Myron S Cohen; Paul I W de Bakker; David B Goldstein; Kevin V Shianna; Barton F Haynes; Norman L Letvin; Andrew J McMichael; Nelson L Michael; Amy C Weintrob Journal: Cell Host Microbe Date: 2009-05-08 Impact factor: 21.023
Authors: Paul L Auer; Jill M Johnsen; Andrew D Johnson; Benjamin A Logsdon; Leslie A Lange; Michael A Nalls; Guosheng Zhang; Nora Franceschini; Keolu Fox; Ethan M Lange; Stephen S Rich; Christopher J O'Donnell; Rebecca D Jackson; Robert B Wallace; Zhao Chen; Timothy A Graubert; James G Wilson; Hua Tang; Guillaume Lettre; Alex P Reiner; Santhi K Ganesh; Yun Li Journal: Am J Hum Genet Date: 2012-10-25 Impact factor: 11.025
Authors: Kirsten Neudoerffer Kangelaris; Anil Sapru; Carolyn S Calfee; Kathleen D Liu; Ludmila Pawlikowska; John S Witte; Eric Vittinghoff; Hanjing Zhuo; Andrew D Auerbach; Elad Ziv; Michael A Matthay Journal: Chest Date: 2011-12-29 Impact factor: 9.410
Authors: S J Glisovic; Y D Pastore; V Gagne; M Plesa; C Laverdière; J M Leclerc; D Sinnett; M Krajinovic Journal: Pharmacogenomics J Date: 2017-05-23 Impact factor: 3.550
Authors: Raj Kurupati; Steve Tuyishime; Andrew V Kossenkov; Marina Sazanovich; Larissa H Haut; Marcio O Lasaro; Sarah J Ratcliffe; Steven E Bosinger; Diane G Carnathan; Mark Lewis; Louise C Showe; Guido Silvestri; Hildegund C J Ertl Journal: J Leukoc Biol Date: 2012-12-27 Impact factor: 4.962
Authors: E Bouzigon; R Nadif; E E Thompson; M P Concas; S Kuldanek; G Du; M Brossard; N Lavielle; C Sarnowski; A Vaysse; P Dessen; R J P van der Valk; L Duijts; A J Henderson; V W V Jaddoe; J C de Jongste; S Casula; G Biino; M-H Dizier; I Pin; R Matran; M Lathrop; M Pirastu; F Demenais; C Ober Journal: Clin Exp Allergy Date: 2015-04 Impact factor: 5.018